Concepedia

James L. Figarola

JL

Statistics

Publications

21

Citations

807

H-Index

16

Active since

2000

Affiliations

City Of Hope National Medical Center(Current)

Beckman Research Institute

City of Hope

University of Nebraska–Lincoln

James L. Figarola is an author at City Of Hope National Medical Center specializing in medicine, pharmacology, and health sciences.

ORCID

Top concepts

Publications per year

2000–2018

21

Publications

21

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats

Stephen Scott, Sofia Loera, Cynthia Tessler et al. · Diabetologia · 2003 · 95 citations · Full text

, , +8

Proinflammatory Effects of Advanced Lipoxidation End Products in Monocytes

Narkunaraja Shanmugam, James L. Figarola, Yan Li et al. · Diabetes · 2007 · 87 citations · Full text

Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes

James L. Figarola, Narkunaraja Shanmugam, Rama Natarajan et al. · Diabetes · 2007 · 72 citations · Full text

, , +17

Advanced Glycation End Products of DNA: Quantification of <i>N</i><sup>2</sup>-(1-Carboxyethyl)-2′-deoxyguanosine in Biological Samples by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry

Timothy W. Synold, Bixin Xi, Gerald E. Wuenschell et al. · Chemical Research in Toxicology · 2008 · 65 citations

LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells

James L. Figarola, Jyotsana Singhal, Samuel Rahbar et al. · APOPTOSIS · 2014 · 63 citations · Full text

, , +9

1–5 of 21